Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
Not your usual blog….
A different sort of blog this week, breaking the usual fortnightly cycle. I’m blogging today to draw your attention to a number of papers we have published on our new CHD review web-pages. These papers will be considered by our Board’s Task and Finish Group at its meeting on Monday 30 September 2013.
We are taking the slightly unusual step of asking the Group for a steer in parallel with asking for your comments. We wanted our Group to be able to give their steers on these issues now, but we also wanted your views to be taken into account. Realistically, there won’t be enough time for you to consider and comment before the Group meets. That’s OK – let us have your comments and we will ensure that any final decisions (e.g. about the proposed governance model, terms of reference etc.) take full account of your views.
I would like to specifically draw your attention to Item 5: Proposed scope and interdependencies As you will see the paper outlines what we already know about the scope of the review, as well as illustrating those areas where more work is needed before a judgement can be made. We plan to take questions about the scope of the review to the first meeting of the Clinical Advisory Panel on 15 October 2013, and we really do want to feed your views in to that process.
Please let us have any comments on this, or any of the other papers, by Monday 7 October 2013.